Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment

Cephalalgia

Volumn 19, Issue 7, 1999, Pages 676-683

  Gobel H ^a   Heinze, A ^b   Stolze, H ^b   Heinze Kuhn, K ^b   Lindner, V ^b  

^a Kiel Pain Clinic   (Germany)

^b NONE

Author keywords

5HT1B 1D receptor agonist; Clinical application; Subcutaneously administered sumatriptan

Indexed keywords

SUMATRIPTAN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MULTICENTER STUDY; PAIN ASSESSMENT; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANALGESICS; ANTIEMETICS; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; DRUG EVALUATION; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HEADACHE; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT DROPOUTS; PROSPECTIVE STUDIES; RECURRENCE; SAFETY; SEROTONIN AGONISTS; SUMATRIPTAN; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 0032849821     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.1999.019007676.x     Document Type: Article

References (18)

1. Bateman DN. Sumatriptan. Lancet 1993;341:221-4
2. Brown EG, Endersby CA, Smith RN. The safety and tolerability of sumatriptan: an overview. Eur Neural 1991;31:339-344
3. Cady RK, Dexter J, Sargent JD. Efficacy of subcutaneous sumatriptan in repeated episodes of migraine. Neurology 1993;43:1363-8
4. Cady RK, Wendt JK, Kirchner JR. Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1994;265:2831-5
5. Dahlöf C, Ekbom K, Persson L. Clinical experiences from Sweden on the use of subcutaneously administered sumatriptan in migraine and cluster headache. Arch Neurol 1994;51:1256-61
6. Ensink FBM Subcutaneous sumatriptan in the acute treatment of migraine. J Neurol 1991;238:66-9
7. Göbel H, Stolze H, Dworschak Heinze A. Easy therapeutical management of sumatriptan-induced daily headache. Neurology 1996;47:297-8
8. Göbel H. Die Kopfschmerzen. Ursachen, Mechanismen, Diagnostik und Therapie in der Praxis. Heidelberg, Berlin, New York: Springer Verlag, 1996:1-812
9. Hulme A, Dalton DW. The efficacy of subcutaneous sumatriptan in the treatment of headache recurrence. Cephalalgia 1993;13 Suppl 13:157
10. Pilgrim AJ. Long-term tolerability, safety and efficacy of sumatriptan. Cephalatgia 1993;13 Suppl 13:190
11. Pilgrim AJ, Blakeborough. The clinical efficacy of sumatriptan in the acute treatment of migraine. Rev Contemp Pharmacother 1994;5:295-309
12. Plosker GL, McTavish D. Sumatriptan - a reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1994;47:622-51
13. Schoenen J, Bulcke J, Caekebeke J. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in art open, longitudinal study. Cephalalgia 1994;14:55-63
14. Tansey MJB, Pilgrim AJ, Martin PM. Long-term experience with sumatriptan in the treatment of migraine. Eur Neurol 1993;33:310-5
15. The Oral Sumatriptan and Aspirin and Metoclopramide- Comparative Study Group. A study to compare oral sumatriptan with oral aspirin and metoclopramide in the acute treatment of migraine. Eur Neurol 1992;32:177-84
16. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991;325:316-21
17. Visser WH. Docs a combined regimen of subcutaneous sumatriptan followed by oral prevent headache recurrence? Cephalalgia 1993;13 Suppl 13:189
18. Visser WH, de Vriend RHM, Jaspers NMWH, Ferrari MD. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology 1996;47:46-51